11 Followers on Owler
OverviewCompetitorsNews & Insights

Ascellna Competitors or Alternatives

Ascellna's top competitors include Inhibrx, BioAtla and Assay Biotech.

Unlock 17 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Ascellna's company profile

Ivan Plavec

Managing Partner

70/100
$0
  • $0
  • $0
  • 70/100
  • $0
View ProfileView
1
Ascellna's Competitor - Inhibrx logo

Mark Lappe

Founder & CEO

98/100
172
$807.8M
$ < 1M
  • $807.8M
    $ < 1M
  • 172
    $807.8M
  • $ < 1M
  • 98/100
  • 172
  • $807.8M
  • $ < 1M
View ProfileView
2
Ascellna's Competitor - BioAtla logo

Jay M. Short

Chairman & CEO

74/100
60
$236.5M
$11M
  • $236.5M
    $11M
  • 60
    $236.5M
  • $11M
  • 74/100
  • 60
  • $236.5M
  • $11M
View ProfileView
3
Ascellna's Competitor - Assay Biotech logo

Allan Peng

CEO

90/100
25 - 100
- -
$100K - 5M
  • - -
    $100K - 5M
  • 25 - 100
    - -
  • $100K - 5M
  • 90/100
  • 25 - 100
  • - -
  • $100K - 5M
View ProfileView
4
Ascellna's Competitor - Nektar logo

Howard W. Robin

President & CEO

91/100
220
$1.1B
$98.4M
  • $1.1B
    $98.4M
  • 220
    $1.1B
  • $98.4M
  • 91/100
  • 220
  • $1.1B
  • $98.4M
View ProfileView
5
Ascellna's Competitor - Sutro Biopharma logo

CEO

- -
240
$570.3M
$62M
  • $570.3M
    $62M
  • 240
    $570.3M
  • $62M
  • - -
  • 240
  • $570.3M
  • $62M
View ProfileView
Ascellna's top 20 competitors are Inhibrx, BioAtla, Assay Biotech, Adimab, Nektar, Sutro Biopharma, GSK, Ambrx, Crescendo Biologics, ALX Oncology, Polaris, Surface Oncology, Five Prime, Proteios, Genmab, BioVision, NBE Therapeutics, CytomX, Agenus and Regeneron. Together they have raised over 10.6B between their estimated 86.1K employees.

Ascellna VS Inhibrx

Inhibrx is Ascellna's biggest rival. Inhibrx was founded in 2010, and is headquartered in La Jolla, California. Like Ascellna, Inhibrx also works within the Pharmaceuticals & Biotechnology sector. Inhibrx generates $200K more revenue vs. Ascellna.

Ascellna VS BioAtla

BioAtla is one of Ascellna's top competitors. BioAtla's headquarters is in San Diego, California, and was founded in 2007. Like Ascellna, BioAtla also works within the Biotechnology sector. BioAtla generates ∞% of Ascellna's revenue.

Looking for similar companies to Ascellna?

Similar Companies

Biotechnology companies

See 29,722 companies 
Pharmaceuticals & Biotechnology companies

See 53,753 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Ascellna and Ascellna's Competitors

April 8, 2025Pharmabiz
ABL Bio Inc., a clinical─stage biotech company developing bispecific antibody technology for immuno─oncology and neurodegenerative diseases, announced ...
April 8, 2025Pharmaceutical Business Review
ALX2004 has been designed using the company's topoisomerase I inhibitor payload platform to enhance anti-tumour activity and improve patient outcomes i...
April 7, 2025PR-Inside
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / April 7, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies in...
April 7, 2025PMLiVE
The licensing deal will give GSK access to ABL Bio's blood-brain barrier shuttle platform...
April 9, 2025Openpr
The Cephalosporin Drugs Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers. It enco...
April 9, 2025Openpr
DelveInsight's "Meningioma Market Insights, Epidemiology, and Market Forecast-2032" Report delivers an in-depth understanding of the Meningioma, histor...
April 7, 2025MedCity News
GSK is licensing an ABL Bio technology yields bispecific antibodies engineered to leverage a certain transmembrane receptor to cross the blood-brain ba...
April 8, 2025Openpr
Global Panic Attack Treatment Market is estimated to be valued at USD 2.92 Bn in 2025 and is expected to reach USD 8.66 Bn in 2032, exhibiting a compou...

Frequently Asked Questions about Ascellna

  1. Who are Ascellna's top competitors?

    Ascellna's top 3 competitors are Inhibrx, BioAtla, Assay Biotech.

  2. Who is similar to Ascellna?

    Inhibrx is the most similar to Ascellna. BioAtla and Assay Biotech are also similar to Ascellna.

  1. Are Ascellna and Inhibrx competitors?

    Yes, Inhibrx is one of Ascellna’s top competitors.